Starry(SH:603520) Sou Hu Cai Jing·2025-07-31 09:37Core Viewpoint - The stock price of Sitaili reached 11.44 yuan as of July 31, 2025, reflecting a 3.53% increase from the previous trading day, indicating positive market sentiment towards the company [1] Company Performance - Sitaili specializes in the research, production, and sales of pharmaceutical raw materials and intermediates, with products covering various therapeutic areas including anti-infection, cardiovascular, and nervous system [1] - In Q1 2025, the company reported a revenue of 686 million yuan and a net profit of 14.34 million yuan, showcasing its operational performance [1] Government Subsidies - From January 1 to July 30, 2025, Sitaili and its subsidiaries received a total of 5.11 million yuan in government subsidies, with subsidies related to income accounting for 10.41% of the company's audited net profit for the most recent fiscal year [1] Market Activity - On July 31, 2025, the net inflow of main funds into Sitaili amounted to 24.37 million yuan, indicating strong investor interest [1]